For prescription topical GHK-Cu used consistently, expect initial texture and hydration improvements at 2 to 4 weeks, meaningful changes to firmness and fine lines at 4 to 8 weeks, maximum early results at 8 to 12 weeks, and full cumulative benefit at 3 to 6 months
2023;39(8):e3693
B12 helps convert the food you eat into glucose, providing energy

Aggressive simultaneous protocol (higher risk) Simultaneous start (both from week 1): Tirzepatide standard titration: Same as conservative: 2.5mg 12.5mg over 16 weeks Cagrilintide standard titration (parallel): Weeks 1-4: 0.6mg weekly Weeks 5-8: 1.2mg weekly Weeks 9-12: 1.8mg weekly Week 13+: 2.4mg weekly Aggressive dosing table: Why this is risky: Compounding side effects from start Very difficult to tolerate High dropout risk Unclear if any additional benefit Both hitting stomach simultaneously Potential maximum weight loss: 20-30% body weight (theoretical) Example: 240 lbs 168-192 lbs (48-72 lbs lost) But tolerability extremely questionable Who might attempt: Exceptional GI tolerance Prior success with GLP-1s without nausea Closely monitored by physician Willing to accept high side effect risk Can afford $1,200-2,400/month Understands experimental nature Lower cagrilintide doses with tirzepatide Moderate approach: Tirzepatide: Standard titration to 10-15mg Cagrilintide: Maximum 1.2-1.8mg (lower than standard 2.4mg) Rationale: Tirzepatide doing heavy lifting already Cagrilintide just adds amylin pathway Don't need maximum cagrilintide dose Better tolerability Significantly lower cost Moderate dosing comparison: Verdict: Lower cagrilintide doses (0.6-1.2mg) might be tolerable but benefit questionable

Studies show that it can: Make wrinkles look up to 35% less deep Increase skin thickness by about 17% Improve skin firmness by up to 20% Reduce dark spots by about 33% Help heal scars and marks One study watched 71 women who used GHK-Cu face cream for 12 weeks
This therapy can help almost anyone with a hangover